FDA Inspection 1029992 — Sartorius Stedim Biooutsource Limited
The FDA completed an inspection of Sartorius Stedim Biooutsource Limited on September 13, 2017 in Glasgow. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 13, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Glasgow (United Kingdom)